These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2889813)

  • 21. The role of β-blockers in the management of hypertension: an Asian perspective.
    Tomlinson B; Dalal JJ; Huang J; Low LP; Park CG; Rahman AR; Reyes EB; Soenarta AA; Heagerty A; Follath F
    Curr Med Res Opin; 2011 May; 27(5):1021-33. PubMed ID: 21410302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [How and to what extent has beta-blocker treatment been established for chronic heart failure?].
    Yokota Y
    J Cardiol; 1996 Aug; 28(2):99-112. PubMed ID: 8814528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do we need a new classification of beta-blockers?
    Kendall MJ
    J Hum Hypertens; 1990 Jun; 4 Suppl 2():27-9. PubMed ID: 1973460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-blockers for primary prevention in hypertension: era bygone?
    Panjrath GS; Messerli FH
    Prog Cardiovasc Dis; 2006; 49(2):76-87. PubMed ID: 17046433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Do beta-blockers have a role in the modern treatment of arterial hypertension?].
    Horký K
    Vnitr Lek; 1996 Jun; 42(6):420-5. PubMed ID: 8928415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Third generation beta blockers in the treatment of hypertension].
    Widimský J
    Vnitr Lek; 1992 May; 38(5):417-25. PubMed ID: 1354908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discordant effects of beta-blockade on central aortic systolic and brachial systolic blood pressure: considerations beyond the cuff.
    Epstein BJ; Anderson S
    Pharmacotherapy; 2007 Sep; 27(9):1322-33. PubMed ID: 17723086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
    Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary prevention with beta-blockade in patients with hypertension: review of results and clinical implications.
    Wikstrand J
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S64-75. PubMed ID: 11527139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-blockers for treatment of hypertension.
    Basile JN; Cohen JD
    Postgrad Med; 2003 Dec; 114(6 Suppl Role):11-7. PubMed ID: 19667665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical use of beta blockers in hypertension.
    Sleight P
    Aviat Space Environ Med; 1981 Nov; 52(11 Pt 2):S3-8. PubMed ID: 6118120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How useful are beta-blockers in cardiovascular disease?
    Bangalore S; Parkar S; Messerli FH
    Anadolu Kardiyol Derg; 2006 Dec; 6(4):358-63. PubMed ID: 17162285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study on intervention in arterial hypertension. Recommendations by experts and practical antihypertensive therapy. German Hypertension League].
    Trenkwalder P
    Fortschr Med; 1999 Feb; 117(6):24, 25-8, 30 passim. PubMed ID: 10095298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta blockers in hypertension: a review.
    Kelly KL
    Am J Hosp Pharm; 1976 Dec; 33(12):1284-90. PubMed ID: 11687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood pressure, diabetes and diabetic nephropathy.
    Chantrel F; Moulin B; Hannedouche T
    Diabetes Metab; 2000 Jul; 26 Suppl 4():37-44. PubMed ID: 10922972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Beta-blockers and arterial hypertension. Evidence-based medicine or excessive perseverance?].
    Verdecchia P; Angeli F; Achilli P; Castellani C; Repaci S; Ambrosio G
    G Ital Cardiol (Rome); 2007 Sep; 8(9):552-8. PubMed ID: 17972424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Beta-adrenergic receptor blockers in clinical practice].
    Czuriga I; Edes I
    Orv Hetil; 2004 Sep; 145(38):1951-60. PubMed ID: 15535106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapy of heart failure with beta-blockers?].
    Osterziel KJ; Dietz R
    Z Kardiol; 1997 Jan; 86(1):1-8. PubMed ID: 9133118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future?
    Dahlöf B; Devereux RB; Kjeldsen SE; Lyle PA; Zhang Z; Edelman JM
    Blood Press; 2007; 16(1):6-12. PubMed ID: 17453746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.